AZN
AstraZeneca PLC · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders -4.3% ·
aandelenstroom -4.1% ·
netto nieuwe posities -4.5%
· formule
Brede distributie: dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 3.19M | $514.55M | n/a | −2 |
| Q2 2026 | 154 | +6 | 584.53M | $109.90B | +11 | −6 |
| Q1 2026 | 151 | +2 | 571.10M | $111.81B | +21 | −20 |
| Q4 2025 | 148 | 0 | 438.95M | $40.35B | +2 | −1 |
| Q3 2025 | 24 | 0 | 219.30M | $16.82B | +1 | −2 |
| Q2 2025 | 22 | -1 | 189.68M | $13.26B | n/a | −1 |
| Q1 2025 | 21 | 0 | 171.06M | $12.57B | n/a | n/a |
| Q4 2024 | 21 | +3 | 174.28M | $11.42B | +3 | n/a |
| Q3 2024 | 17 | -3 | 166.39M | $12.97B | n/a | −3 |
| Q2 2024 | 20 | n/a | 172.48M | $13.45B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 51.94M | -9.0% | $3.63B | 0.4% | ▼ Trim | 5 | SEC ↗ ×2 |
| 2 | PRIMECAP Management ✦ | 41.20M | +1.3% | $2.88B | 2.3% | ▲ Add | 5 | SEC ↗ |
| 3 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ ×8 |
| 4 | Fidelity (FMR) ✦ | 21.34M | n/a | $1.49B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 5 | Fisher Asset Management ✦ | 20.70M | +2.6% | $1.45B | 0.6% | ▲ Add | 5 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 5.49M | n/a | $383.47M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 7 | Marshall Wace ✦ | 2.00M | +45.3% | $139.76M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 1.90M | +12.2% | $133.12M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 1.83M | -10.5% | $127.95M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 10 | Point72 Asset Management ✦ | 1.69M | +41.9% | $117.79M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.30M | +335.8% | $91.11M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 1.16M | -67.8% | $80.75M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.14M | +20.3% | $79.97M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (passief) | 939.00K | -6.0% | $65.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 858.50K | +88.9% | $59.99M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 620.90K | -10.2% | $43.39M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passief) | 505.06K | +2.9% | $35.29M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 325.39K | -49.7% | $22.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Capital World Investors ✦ | 153.56K | +2.8% | $10.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Dodge & Cox ✦ | 137.49K | +1.0% | $9.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Norges Bank ✦ (passief) | 60.38K | +268.6% | $4.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 53.94K | +43.9% | $3.77M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Soros Fund Management | $201.57M | was 5.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,307 houders, 729.50M aandelen, $139.69B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer · See Remarks · 20 aand @ 160.57 · $3,249
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie